Tripura Merger Agreement

Aimfinity Investment Corp. I enters into Definitive Merger Agreement with Taiwanese smart medical device developer Docter Inc.

Retrieved on: 
Monday, October 16, 2023
Cloud, Investment, Health, Partnership, MOU, Acquisition, Myocardial infarction, COVID-19, LLP, Registration statement, Holly Steam Combination Company, Winston & Strawn, Tripura Merger Agreement, Capital market, Long-term care, Growth, Harvard Medical School, Earnout, Register, Security (finance), Docter

The company operates Docter brand watches and employs Docter Cloud platform technologies to facilitate health monitoring, vascular elasticity tracking, and myocardial infarction prediction.

Key Points: 
  • The company operates Docter brand watches and employs Docter Cloud platform technologies to facilitate health monitoring, vascular elasticity tracking, and myocardial infarction prediction.
  • In addition to this exciting transaction, Docter Inc. has recently announced that it has signed a Memorandum of Understanding (MOU) with Harvard Medical School for the purchase of 10,000 Docter watches.
  • These watches will be utilized in a Harvard Medical School Long Covid research project, highlighting the growth potential of Docter Inc.'s technology in advanced medical research.
  • US Tiger Securities is serving as M&A and Capital Markets advisor and Robinson & Cole LLP is serving as legal advisor to Aimfinity.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Pioneer Natural Resources (NYSE - PXD), Bsquare Corporation (Nasdaq - BSQR), Genetron Holdings Limited (Nasdaq - GTH), SP® Plus Corporation (Nasdaq - SP)

Retrieved on: 
Thursday, October 12, 2023
NYSE, Bsquare, XOM, Metropolis, Parent, ExxonMobil, Tripura Merger Agreement, Brodsky, Pioneer, Security (finance)

BALA CYNWYD, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, Pioneer will be acquired by Exxon Mobil (NYSE – XOM).
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

Cegeka and CTG Announce Extension of Tender Offer for All Outstanding Shares of CTG

Retrieved on: 
Thursday, October 12, 2023
Telephone, Computer Task Group, Computershare, Eastern Time Zone, Agreement, Tender, Bangladesh Securities and Exchange Commission, Finance, Tripura Merger Agreement, Money transmitter, Plan, Letter, CTG, Competition Authority, Security (finance), Incorporated, Cegeka

Computershare, the depositary for the Offer, has indicated that as of 5:00 p.m., Eastern Time, on October 11, 2023, approximately 8,259,806.406 Shares had been validly tendered into and not validly withdrawn from the Offer, representing approximately 53.6755% of the outstanding Shares.

Key Points: 
  • Computershare, the depositary for the Offer, has indicated that as of 5:00 p.m., Eastern Time, on October 11, 2023, approximately 8,259,806.406 Shares had been validly tendered into and not validly withdrawn from the Offer, representing approximately 53.6755% of the outstanding Shares.
  • Shareholders that have previously tendered their Shares do not need to re-tender their Shares or take any other action in response to this extension.
  • The Offer was extended to allow additional time to satisfy the Regulatory Conditions and the other conditions described in the Offer to Purchase.
  • Requests for documents and questions regarding the Offer may be directed to Georgeson by telephone at 1-866-431-2096.

Genetron Health Enters into Definitive Merger Agreement for Going Private Transaction

Retrieved on: 
Wednesday, October 11, 2023
Slate, Canadian House of Commons Special Committee on Electoral Reform, LLP, King & Wood Mallesons, Skadden, Arps, Slate, Meagher & Flom, Consortium, Schedule, Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, US, Wardwell, Form 6-K, Tripura Merger Agreement, CICC, Person, Neal, Sub, Latham & Watkins, Proxy, Committee, Limited partnership, GTH, III, ODI, ADS, CCB, AND, Holding company, Security (finance), Auction, PRC, Parent, Share (finance), Mergers and acquisitions

BEIJING, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced today that it has entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with New Genetron Holding Limited (“Parent”) and Genetron New Co Limited (“Merger Sub”), a wholly-owned subsidiary of Parent.

Key Points: 
  • BEIJING, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced today that it has entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with New Genetron Holding Limited (“Parent”) and Genetron New Co Limited (“Merger Sub”), a wholly-owned subsidiary of Parent.
  • The Board, acting upon the unanimous recommendation of a committee of independent and disinterested directors established by the Board (the “Special Committee”), approved the Merger Agreement and the Merger and resolved to recommend the Company’s shareholders vote to authorize and approve the Merger Agreement and the Merger.
  • The Special Committee negotiated the terms of the Merger Agreement with the assistance of its financial and legal advisors.
  • In connection with the Merger, the Company will prepare and mail to its shareholders a proxy statement that will include a copy of the Merger Agreement.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mirati Therapeutics, Inc.® (Nasdaq - MRTX), LiveVox Holdings, Inc. (Nasdaq - LVOX), SP® Plus Corporation (Nasdaq - SP), Summit Materials (NYSE - SUM)

Retrieved on: 
Monday, October 9, 2023
Nice, NYSE, Bristol Myers Squibb, Metropolis, NICE Ltd., Argos, Tripura Merger Agreement, Brodsky, CVR, BMY, Security (finance), Mirati

BALA CYNWYD, Pa., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • The deal has a total equity value of $4.8 billion corresponding to an enterprise value of approximately $3.7 billion, which accounts for approximately $1.1 billion of Mirati cash.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio

Retrieved on: 
Friday, October 6, 2023
Proxy, Agreement, Special dividend, Tripura Merger Agreement, Therapy, Plan, Holding company, Talari Manohar, Mergers and acquisitions

BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS) (“Talaris” or the “Company”) today announced that its Board of Directors has declared a special dividend in connection with the previously announced merger (the “Merger”) with Tourmaline Bio, Inc. (“Tourmaline”) pursuant to the Agreement and Plan of Merger, dated June 22, 2023 (the “Merger Agreement”).

Key Points: 
  • Payment of special dividend conditioned upon closing of merger, which is subject to stockholder approval
    BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS) (“Talaris” or the “Company”) today announced that its Board of Directors has declared a special dividend in connection with the previously announced merger (the “Merger”) with Tourmaline Bio, Inc. (“Tourmaline”) pursuant to the Agreement and Plan of Merger, dated June 22, 2023 (the “Merger Agreement”).
  • The special dividend, which the Company estimates will be $1.5118 per share of Talaris common stock, will be payable in cash.
  • The exact amount of the special dividend will be calculated after deducting certain cash amounts as set forth in the Merger Agreement.
  • Payment of the special dividend is conditioned upon the closing of the Merger with Tourmaline, which remains subject to the approval of Talaris’ stockholders and other closing conditions.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP® Plus Corporation (Nasdaq - SP), Orchard Therapeutics plc (Nasdaq - ORTX), Summit Materials (NYSE - SUM)

Retrieved on: 
Thursday, October 5, 2023
Metropolis, Kyowa Kirin, ADS, Argos, Tripura Merger Agreement, Brodsky, Orchard, Security (finance)

BALA CYNWYD, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the Merger Agreement, SP+ will be acquired by Metropolis Technologies, Inc. (“Metropolis”) for $54.00 per share in cash for each share of SP+ held.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

Silicon Motion Files Notice of Arbitration Claim Against MaxLinear

Retrieved on: 
Thursday, October 5, 2023
Singapore International Arbitration Centre, Tripura Merger Agreement, SIAC, NAND, MaxLinear, Marketing, Silicon, SIMO, Practice of law

TAIPEI, Taiwan and MILPITAS, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NASDAQGS: SIMO) (“Silicon Motion” or “the Company”), a global leader in designing and marketing NAND flash controllers for solid state storage devices, today commenced an arbitration against MaxLinear, Inc. for breaching its May 5, 2022 agreement to acquire the Company (the “Merger Agreement”).

Key Points: 
  • TAIPEI, Taiwan and MILPITAS, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NASDAQGS: SIMO) (“Silicon Motion” or “the Company”), a global leader in designing and marketing NAND flash controllers for solid state storage devices, today commenced an arbitration against MaxLinear, Inc. for breaching its May 5, 2022 agreement to acquire the Company (the “Merger Agreement”).
  • The claim was filed in the Singapore International Arbitration Centre (“SIAC”), as provided under the Merger Agreement.
  • In the arbitration, the Company seeks payment of the termination fee of $160 million, further substantial damages, interest and costs.
  • Under the SIAC Arbitration Rules, all matters relating to the proceedings are confidential.

JetBlue Announces Record and Payment Dates for October 2023 Additional Prepayment to Spirit Stockholders

Retrieved on: 
Friday, October 13, 2023
Other Travel, Transportation, Destinations, Travel, Vacation, Air, Transport, Tourist Attractions, JetBlue, JBLU, Tripura Merger Agreement, NYSE, Agreement, Plan, Airline, Spirit

As previously announced, in connection with the Agreement and Plan of Merger, dated as of July 28, 2022 (the “Merger Agreement”), by and among JetBlue Airways Corporation (“JetBlue”) (NASDAQ: JBLU), Sundown Acquisition Corp., and Spirit Airlines, Inc. (“Spirit”) (NYSE: SAVE), JetBlue has set October 25, 2023, as the record date for the October 2023 prepayment to Spirit stockholders of $0.10 per Spirit share (the “October 2023 Additional Prepayment”), with payment of the October 2023 Additional Prepayment to occur on October 31, 2023.

Key Points: 
  • As previously announced, in connection with the Agreement and Plan of Merger, dated as of July 28, 2022 (the “Merger Agreement”), by and among JetBlue Airways Corporation (“JetBlue”) (NASDAQ: JBLU), Sundown Acquisition Corp., and Spirit Airlines, Inc. (“Spirit”) (NYSE: SAVE), JetBlue has set October 25, 2023, as the record date for the October 2023 prepayment to Spirit stockholders of $0.10 per Spirit share (the “October 2023 Additional Prepayment”), with payment of the October 2023 Additional Prepayment to occur on October 31, 2023.
  • Pursuant to the Merger Agreement, Spirit stockholders as of the October 25, 2023, record date will be entitled to receive the October 2023 Additional Prepayment.

Chase Corporation Announces October 6, 2023 Special Meeting Results

Retrieved on: 
Friday, October 6, 2023
Chemicals, Plastics, Asset Management, Professional Services, Manufacturing, Risk, Communication, Tripura Merger Agreement, Xi, Mergers and acquisitions, Swings, Vii, Security (finance), Cryptocurrency, Bank

All such forward-looking statements are intended to provide management’s current expectations for the future of the Company based on current expectations and assumptions relating to the Company’s business, the economy and other future conditions.

Key Points: 
  • All such forward-looking statements are intended to provide management’s current expectations for the future of the Company based on current expectations and assumptions relating to the Company’s business, the economy and other future conditions.
  • Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict.
  • Accordingly, actual results may differ materially from those contemplated by these forward-looking statements.
  • Investors, therefore, are cautioned against relying on any of these forward-looking statements.